510(k) Report

510(k) · Cleared

Cleared

Therapax DXT 300 Series 3

K923584510(k) TraditionalCleared Jan 15, 1993179-day reviewClass II21 CFR 892.5900

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oldelft Corp. of America · JAD System, Therapeutic, X-Ray

Cleared on Jan 15, 1993 after a 179-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

Decided
Jan 15, 1993
Review
179 days
Class
Class II
Product code
JAD
Recalls
None
Predicates
0

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

FIG. 1 — Lineage of K923584Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAD device

  1. #1 K241174 INTRABEAM (700); And accessories (INTRABEAM…score 11.7 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All JAD devices

JAD System, Therapeutic, X-Ray: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JAD

2in 2025

2007: 12008: 22009: 32011: 12012: 22013: 52014: 12015: 12016: 22017: 12018: 12019: 22022: 12023: 12025: 2
2007high 5 (2013) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAD

114in 2013

2009: 106 days median2013: 114 days median
2007high 114 (2013) · low 106 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAD

2in 2021

2009: 22011: 12012: 32017: 12021: 22026 (partial year): 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAD

1in 2025

2007: 22008: 22009: 52011: 32012: 42013: 122014: 42015: 52016: 52017: 32018: 12019: 92022: 52023: 22024: 52025: 1
2007high 12 (2013) · low 0 (2010)2025

MAUDE reports naming product code JAD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20082—02
2009310625
20100—00
20111—13
20122—34
20135114012
20141—04
20151—05
20162—05
20171—13
20181—01
20192—09
20200—00
20210—20
20221—05
20231—02
20240—05
20252—01
20260—1—
Cite this page

510(k) Report. “K923584: Therapax DXT 300 Series 3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K923584

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026